The RADAR-AD project was an innovative research initiative focusing on the use of mobile and digital technologies to improve the assessment of Alzheimer's disease (AD). This project embraced a contemporary understanding of AD, acknowledging its entire spectrum, from the pre-dementia stages (including preclinical and prodromal AD) to the dementia phases, ranging from mild to severe AD dementia.
RADAR-AD leveraged insights and methodologies developed in its sister project, RADAR-CNS (Remote Assessment of Disease and Relapse – Central Nervous System). Launched in 2016, RADAR-CNS concentrated on remote monitoring of individuals with multiple sclerosis, epilepsy, and depression. The experiences and knowledge gained from RADAR-CNS were instrumental in shaping RADAR-AD's approach to Alzheimer's disease, particularly in the context of using digital and remote monitoring techniques to better understand and track the progression of the disease.
The RADAR-AD project has received support from the Innovative Medicines Initiative Joint Undertaking (JU) under grant agreement n° 806999. The JU receives support from the European Union’s Horizon2020 research and innovation programme and EFPIA.
